ENTOCORT Budesonide 3mg modified release capsule  bottle Australia - English - Department of Health (Therapeutic Goods Administration)

entocort budesonide 3mg modified release capsule bottle

chiesi australia pty ltd - budesonide, quantity: 3 mg - capsule, modified release - excipient ingredients: sodium lauryl sulfate; iron oxide yellow; tributyl acetylcitrate; colloidal anhydrous silica; titanium dioxide; liquid paraffin; dimeticone 1000; purified talc; iron oxide black; ethylcellulose; gelatin; triethyl citrate; methacrylic acid copolymer; iron oxide red; polysorbate 80; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; ethanol; shellac; strong ammonia solution; potassium hydroxide; maize starch; sucrose - the induction of remission in adult patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

Entocort New Zealand - English - Medsafe (Medicines Safety Authority)

entocort

chiesi new zealand limited t/a emerge health - budesonide 3mg - modified release capsule - 3 mg - active: budesonide 3mg excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid - ethyl acrylate copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate - entocort capsules are indicated for the induction of remission in patients with mild to moderate crohn's disease affecting the ileum and/or the ascending colon.

Entocort 3 mg hard caps. modif.-rel. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

entocort 3 mg hard caps. modif.-rel.

tillotts pharma gmbh - budesonide, micronised 3 mg - modified-release capsule, hard - 3 mg - budesonide 3 mg - budesonide

Entocort New Zealand - English - Medsafe (Medicines Safety Authority)

entocort

astrazeneca limited - budesonide 2.25mg;  ;   - modified release capsule - 2.25 mg - active: budesonide 2.25mg     excipient: acetyl tributyl citrate ethylcellulose gelatin methacrylic acid copolymer polysorbate 80 purified talc simeticone sugar spheres triethyl citrate